Date updated:03-26-2007
CAPITAL GROWTH STRATEGY: The Capital Growth Strategy purchases stocks based on the coupling of high returns on equity/assets/capital at attractive valuations and tracks earnings estimate revisions to confirm buy and sell points.

-
AAPL
Apple Inc. - $194.34
- +0.16%
- $193.00
No Analysis added

-
ACN
Accenture Plc. - $39.25
- +0.72%
- $38.82
No Analysis added

-
AIZ
Assurant Inc - $30.83
- +0.69%
- $30.26
No Analysis added

-
ARO
Aeropostale Inc - $33.70
- +0.69%
- $32.74
No Analysis added

-
ARP
American Repro Co - $6.26
- +9.82%
- $6.29
No Analysis added

-
BAC
Bk Of America Cp - $15.05
- -0.53%
- $14.94
No Analysis added

-
BUD
Anh Bsch Inb Sa A - $48.37
- -0.45%
- $48.52
No Analysis added

-
CAT
Caterpillar Inc - $57.60
- -0.67%
- $57.38
No Analysis added
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. Type II Diabetes in obese patients is
wrecking our health care system.
Overall, more than $1 in every $10 spent
on health care in the United States goes
toward treating Diabetes. Blood glucose
test strips alone can cost about a
dollar each and if you're testing
several times a day every day, the costs
can add up pretty quickly. XOMA has the
first drug "XOMA 052" in the last 10yrs
which will significantly impact this
industry and you would no longer require
daily insulin injections or insulin at
all, for that matter. This would save
the government billions, search on that
one and you'll make a fortune. The
government cannot continue to pay these
kinds of rising diabetes costs, when
there is an alternative which is so safe
and so effective which just became
patented in Europe.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
Analyst Upgrades for Nov. 2, 2009. Read more here. more
Here is the stock list of some of the largest % losers from Nov. 2, 2009. more













Comments not available